PUR THERAPIES
0827.376.049 · rovalta.com · 25/09/2026
JUDICIAL DISSOLUTION OR NULLITY
PUR THERAPIES
Company — Judicial dissolution or nullity.
Financial year 2021 · Closed on 31/12/2021
Net result-5,6 k €-102,0 %over 1 year
Gross margin-3,5 k €-101,0 %over 1 year
Equity428,1 k €-1,3 %over 1 year
Overview
Identity
Source · BCE/KBOPUR THERAPIES is a Private company with limited liability incorporated in 2010. Its registered office is in Sivry-Rance.
- Legal situation
- Judicial dissolution or nullity
- BCE/KBO no. / VAT
- BE 0827.376.049
- Incorporation
- 30/06/2010
- Legal form
- Private company with limited liability
- Registered office
- Rue de la Bretagne 1
6470 Sivry-Rance · WallonieSee on map - Contributed capital
- 200 000,00 €
- Latest accounts
- 31/12/2021
Signals
Solid equityGood liquidity
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -3,5 k € | -101% | 346,8 k € | +1407% | 23 k € | +54.0% | 14,9 k € | +185% | -17,6 k € |
| EBITDA | -4,2 k € | -101% | 346,5 k € | +1734% | 18,9 k € | +82.3% | 10,4 k € | +159% | -17,7 k € |
| Operating result | -4,5 k € | -101% | 346,4 k € | +9115% | 3,8 k € | +135% | -10,7 k € | +39.3% | -17,7 k € |
| Net result | -5,6 k € | -102% | 279 k € | +4360% | -6,5 k € | +65.8% | -19,1 k € | -7.7% | -17,8 k € |
| Balance sheet | |||||||||
| Equity | 428,1 k € | -1.3% | 433,6 k € | +180% | 154,6 k € | -4.1% | 161,2 k € | -14.2% | 187,8 k € |
| Total assets | 721,1 k € | -10.7% | 807,1 k € | +108% | 387,3 k € | -2.4% | 396,9 k € | -9.9% | 440,5 k € |
| Cash | 267,3 k € | -20.9% | 337,7 k € | +13607% | 2,5 k € | +17.3% | 2,1 k € | -17.2% | 2,5 k € |
| Debts | 293 k € | -21.6% | 373,5 k € | +62.1% | 230,3 k € | -2.3% | 235,7 k € | -6.7% | 252,6 k € |
Board of directors
Source · NBB, accounts to 31/12/20212 active · 6 ended
Active mandates
DANIEL PAKULA
ActiveCLAIRE HOFFMANN
ActiveEnded mandates
DANIEL PAKULA
EndedCLAIRE HOFFMANN
EndedClaire Hoffmann
EndedDaniel Pakula
EndedFinancials
Full financial information
Source · NBB| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/01/2023 | 13/12/2021 | 09/11/2020 | 12/09/2019 | 31/08/2018 | 13/11/2017 |
| General meeting | 27/06/2022 | 28/06/2021 | 08/10/2020 | 28/06/2019 | 29/06/2018 | 30/10/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2021 | 27/06/2022 | 31/01/2023 | French | |
| Micro model | 31/12/2020 | 28/06/2021 | 13/12/2021 | French | |
| Micro model | 31/12/2019 | 08/10/2020 | 09/11/2020 | French | |
| Micro model | 31/12/2018 | 28/06/2019 | 12/09/2019 | French | |
| Micro model | 31/12/2017 | 29/06/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 30/10/2017 | 13/11/2017 | French | |
| Abridged model | 31/12/2015 | 28/02/2017 | 09/03/2017 | French | |
| Abridged model | 31/12/2014 | 29/06/2015 | 25/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 20/08/2014 | French | |
| Abridged model | 31/12/2012 | 24/06/2013 | 28/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/10/2012 | 30/10/2012 | French | |
| Abridged model | 31/12/2010 | 28/09/2012 | 28/09/2012 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20212 active · 6 ended
Active mandates
DANIEL PAKULA
ActiveCLAIRE HOFFMANN
ActiveEnded mandates
DANIEL PAKULA
EndedCLAIRE HOFFMANN
EndedClaire Hoffmann
EndedDaniel Pakula
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 2021-5,6 k €↓
- 2021Name changePURTHERAPIES
- 2020Annual accounts 2020279 k €↑
- 2019Annual accounts 2019-6,5 k €↑
- 2018Annual accounts 2018-19,1 k €↓
- 2017Annual accounts 2017-17,8 k €↓
- 2016Annual accounts 2016-14,2 k €↓
- 2015Annual accounts 20153,4 k €↓
- 2014Annual accounts 201413,5 k €↑
- 2013Annual accounts 20135,9 k €↑
- 2012Annual accounts 20122,6 k €↓
- 2011Annual accounts 20114,6 k €↑
- 2010Annual accounts 2010-10,2 k €
- 30/06/2010IncorporationPrivate company with limited liability
- 2010Name changePUR THERAPIES